MBX Biosciences, Inc.
MBX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001776111
In the last 90 days, MBX Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 172 institutions reported holding it in 13F filings for Q2 2026, worth $3.06B in total; no superinvestor holds it.
Holders of 5% or more of MBX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of MBX Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%7.22M shares | +3.80 ppfrom 11.20% | May 6, 20263 filings | Nov 5, 2026 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13D/A | 11.70%5.24M shares | 0.00 ppfrom 11.70% | Sep 23, 20244 filings | Aug 10, 2026 | SEC |
| Wellington Management Group LLP | 13G/A | 10.50%4.98M shares | +3.00 ppfrom 7.50% | Nov 8, 20246 filings | Jul 8, 2026 | SEC |
| New Enterprise Associates 17, L.P. | 13D/A | 8.10%3.62M shares | – | Sep 23, 20242 filings | Nov 10, 2025 | SEC |
| OrbiMed Advisors LLC | 13D/A | 6.40%3.07M shares | −1.30 ppfrom 7.70% | Sep 23, 20244 filings | Aug 10, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.50%2.63M shares | +0.70 ppfrom 4.80% | Jan 21, 20263 filings | Jul 29, 2026 | SEC |
| Paradigm Biocapital Advisors LP | 13G | 5.20%2.49M shares | New | Jun 24, 20261 filing | Jun 24, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
32 Schedule 13D and 13G filings on MBX Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 20261:22 PM ET | FMR LLCand 1 other | 13G/A | 15.00%7.22M shares | +3.80 ppfrom 11.20% | Sep 30, 2026 | SEC |
| Aug 14, 20268:27 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 3.64%1.73M shares | −2.91 ppfrom 6.55%Below 5% | Jun 30, 2026 | SEC |
| Aug 10, 20265:35 PM ET | Frazier Life Sciences Public Fund, L.P.and 10 others | 13D/A | 11.70%5.24M shares | 0.00 ppfrom 11.70% | Aug 6, 2026 | SEC |
| Aug 10, 20264:44 PM ET | OrbiMed Advisors LLCand 2 others | 13D/A | 6.40%3.07M shares | −1.30 ppfrom 7.70% | Aug 6, 2026 | SEC |
| Jul 29, 20263:19 PM ET | BlackRock, Inc. | 13G | 5.50%2.63M shares | +0.70 ppfrom 4.80% | Jun 30, 2026 | SEC |
| Jul 8, 202612:59 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 10.50%4.98M shares | +3.00 ppfrom 7.50% | Jun 30, 2026 | SEC |
| Jul 8, 202610:11 AM ET | FMR LLCand 1 other | 13G/A | 11.20%5.32M shares | +5.00 ppfrom 6.20% | Jun 30, 2026 | SEC |
| Jun 24, 20264:05 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G | 5.20%2.49M shares | New | Jun 16, 2026 | SEC |
| May 6, 202611:30 AM ET | FMR LLCand 1 other | 13G | 6.20%2.94M shares | New | Mar 31, 2026 | SEC |
| Apr 27, 20264:12 PM ET | BlackRock, Inc. | 13G/A | 4.80%2.29M shares | −0.30 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| Feb 11, 20266:42 PM ET | OrbiMed Advisors LLCand 2 others | 13D/A | 7.70%3.64M shares | −1.30 ppfrom 9.00% | Feb 5, 2026 | SEC |
| Feb 10, 202611:21 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 7.50%3.35M shares | −3.30 ppfrom 10.80% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.10%2.27M shares | New | Dec 31, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Hawryluk P. Kent | 13G/A | 4.30%2.00M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 12, 20256:44 PM ET | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 13G/A | 4.50%2.02M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 10, 20255:08 PM ET | New Enterprise Associates 17, L.P.and 11 others | 13D/A | 8.10%3.62M shares | – | Nov 6, 2025 | SEC |
| Oct 6, 202512:22 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 10.80%4.82M shares | +4.00 ppfrom 6.80% | Sep 30, 2025 | SEC |
| Sep 30, 20257:06 PM ET | OrbiMed Advisors LLCand 2 others | 13D/A | 9.00%4.00M shares | – | Sep 26, 2025 | SEC |
| Sep 30, 20256:15 PM ET | Norwest Venture Partners XVI, LPand 5 others | 13D/A | 4.80%2.14M shares | –Below 5% | Sep 26, 2025 | SEC |
| Sep 30, 20255:01 PM ET | Frazier Life Sciences Public Fund, L.P.and 13 others | 13D/A | 11.70%5.22M shares | −1.90 ppfrom 13.60% | Sep 26, 2025 | SEC |
| Aug 20, 20255:23 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13D/A | 13.60%4.56M shares | – | Aug 18, 2025 | SEC |
| Aug 14, 20258:48 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.55%2.19M shares | – | Jun 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 6.80%2.27M shares | −1.10 ppfrom 7.90% | Jun 30, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 7.90%2.64M shares | – | Mar 31, 2025 | SEC |
| Nov 8, 2024 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Nov 1, 2024 | Hawryluk P. Kent | 13GOld format | – | New | – | SEC |
| Sep 23, 2024 | Frazier Life Sciences Public Fund, L.P. | 13DOld format | – | New | – | SEC |
| Sep 23, 2024 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Sep 23, 2024 | Norwest Venture Partners XVI, LP | 13DOld format | – | New | – | SEC |
| Sep 23, 2024 | New Enterprise Associates 17, L.P. | 13DOld format | – | New | – | SEC |
| Sep 23, 2024 | OrbiMed Advisors LLC | 13DOld format | – | New | – | SEC |
| Sep 20, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
19 notices from officers, directors and other affiliates planning to sell MBX Biosciences, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20267:25 PM ET | Hoerter Steven L.Director | 4.89K | $268.2K | Nov 10, 2026 | Fidelity Brokerage Services LLC | SEC |
| Nov 4, 20263:12 PM ET | Azoulay SalomonOfficer | 373 | $20.1K | Nov 4, 2026 | Fidelity Brokerage Services LLC | SEC |
| Aug 17, 20263:41 PM ET | Hawryluk P. KentFormer officer | 3.75K | $255.7K | Aug 17, 2026 | Fidelity Brokerage Services LLC | SEC |
| Aug 4, 20264:44 PM ET | Hawryluk P. KentOfficer · Director | 936 | $61.6K | Aug 4, 2026 | Fidelity Brokerage Services LLC | SEC |
| Aug 4, 20264:42 PM ET | Azoulay SalomonOfficer | 370 | $24.3K | Aug 4, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jun 10, 202612:41 PM ET | Bartram RichardFormer officer | 9.17K | $280.0K | Jun 10, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jun 9, 20264:38 PM ET | Bartram RichardFormer officer | 10.8K | $321.3K | Jun 9, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 13, 20264:17 PM ET | Bartram RichardFormer officer | 15.0K | $554.3K | May 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 11, 20263:54 PM ET | Bartram RichardFormer officer | 22.5K | $991.9K | May 11, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 8, 20264:10 PM ET | Azoulay SalomonOfficer | 70.0K | $2.69M | May 8, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 8, 202612:21 PM ET | Bartram RichardFormer officer | 10.0K | $379.6K | May 8, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 7, 202612:47 PM ET | Bartram RichardFormer officer | 10.0K | $322.1K | May 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 6, 20263:29 PM ET | Hawryluk P. KentOfficer · Director | 607 | $17.9K | May 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 6, 20263:12 PM ET | Azoulay SalomonOfficer | 231 | $6.82K | May 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 1, 20262:59 PM ET | Bartram RichardFormer officer | 5.00K | $159.0K | May 1, 2026 | Fidelity Brokerage Services LLC | SEC |
| Apr 22, 202611:59 AM ET | Bartram RichardFormer officer | 10.4K | $341.4K | Apr 22, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 25, 20263:20 PM ET | Bartram RichardFormer officer | 1.06K | $30.2K | Mar 25, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 16, 20262:47 PM ET | Bartram RichardFormer officer | 10.0K | $300.5K | Mar 16, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jan 12, 20263:41 PM ET | Cornelius James MFormer director | 30.9K | $1.10M | Jan 12, 2026 | Fidelity Brokerage Services LLC | SEC |